The role of empagliflozin in the management of type 2 diabetes by patient profile
Maka S Hedrington, Stephen N Davis Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA Abstract: Current recommendations for the management of type 2 diabetes mellitus (T2DM) include patient-centered approach, ie, targeting glycemic control based on patient and dise...
Saved in:
Main Authors: | Hedrington MS (Author), Davis SN (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differential pharmacology and clinical utility of empagliflozin in type 2 diabetes
by: Munir KM, et al.
Published: (2016) -
Empagliflozin's role in early tubular protection for type 2 diabetes patients
by: Chuangbiao Zhang, et al.
Published: (2024) -
Evaluating Impact of Empagliflozin on Lipid Profile of Patients of Type 2 Diabetes Mellitus
by: Nauman Wazir, et al.
Published: (2022) -
Empagliflozin in the treatment of type 2 diabetes: evidence to date
by: Shubrook JH, et al.
Published: (2015) -
Efficacy and Safety of Empagliflozin as Add-On Therapy in Patients of Type-2 Diabetes Mellitus
by: Nauman Wazir, et al.
Published: (2022)